Callahan Christopher M, Boustani Malaz A, Unverzagt Frederick W, Austrom Mary G, Damush Teresa M, Perkins Anthony J, Fultz Bridget A, Hui Siu L, Counsell Steven R, Hendrie Hugh C
Indiana University Center for Aging Research, Regenstrief Institute Inc, Indiana University School of Medicine, Indianapolis 46202, USA.
JAMA. 2006 May 10;295(18):2148-57. doi: 10.1001/jama.295.18.2148.
Most older adults with dementia will be cared for by primary care physicians, but the primary care practice environment presents important challenges to providing quality care.
To test the effectiveness of a collaborative care model to improve the quality of care for patients with Alzheimer disease.
DESIGN, SETTING, AND PATIENTS: Controlled clinical trial of 153 older adults with Alzheimer disease and their caregivers who were randomized by physician to receive collaborative care management (n = 84) or augmented usual care (n = 69) at primary care practices within 2 US university-affiliated health care systems from January 2002 through August 2004. Eligible patients (identified via screening or medical record) met diagnostic criteria for Alzheimer disease and had a self-identified caregiver.
Intervention patients received 1 year of care management by an interdisciplinary team led by an advanced practice nurse working with the patient's family caregiver and integrated within primary care. The team used standard protocols to initiate treatment and identify, monitor, and treat behavioral and psychological symptoms of dementia, stressing nonpharmacological management.
Neuropsychiatric Inventory (NPI) administered at baseline and at 6, 12, and 18 months. Secondary outcomes included the Cornell Scale for Depression in Dementia (CSDD), cognition, activities of daily living, resource use, and caregiver's depression severity.
Initiated by caregivers' reports, 89% of intervention patients triggered at least 1 protocol for behavioral and psychological symptoms of dementia with a mean of 4 per patient from a total of 8 possible protocols. Intervention patients were more likely to receive cholinesterase inhibitors (79.8% vs 55.1%; P = .002) and antidepressants (45.2% vs 27.5%; P = .03). Intervention patients had significantly fewer behavioral and psychological symptoms of dementia as measured by the total NPI score at 12 months (mean difference, -5.6; P = .01) and at 18 months (mean difference, -5.4; P = .01). Intervention caregivers also reported significant improvements in distress as measured by the caregiver NPI at 12 months; at 18 months, caregivers showed improvement in depression as measured by the Patient Health Questionnaire-9. No group differences were found on the CSDD, cognition, activities of daily living, or on rates of hospitalization, nursing home placement, or death.
Collaborative care for the treatment of Alzheimer disease resulted in significant improvement in the quality of care and in behavioral and psychological symptoms of dementia among primary care patients and their caregivers. These improvements were achieved without significantly increasing the use of antipsychotics or sedative-hypnotics.
clinicaltrials.gov Identifier: NCT00246896.
大多数患有痴呆症的老年人将由初级保健医生照料,但初级保健的执业环境给提供高质量护理带来了重大挑战。
测试一种协作护理模式对改善阿尔茨海默病患者护理质量的有效性。
设计、场所和患者:对153名患有阿尔茨海默病的老年人及其照料者进行的对照临床试验,这些患者由医生随机分组,于2002年1月至2004年8月在美国2个大学附属医疗保健系统内的初级保健机构接受协作护理管理(n = 84)或强化常规护理(n = 69)。符合条件的患者(通过筛查或病历确定)符合阿尔茨海默病的诊断标准且有一名自我认定的照料者。
干预组患者接受由一名高级执业护士领导的跨学科团队为期1年的护理管理,该团队与患者的家庭照料者合作,并融入初级保健。该团队使用标准方案启动治疗,并识别、监测和治疗痴呆症的行为和心理症状,强调非药物管理。
在基线以及6、12和18个月时进行神经精神科问卷(NPI)评估。次要结局包括痴呆症抑郁康奈尔量表(CSDD)、认知、日常生活活动、资源使用以及照料者的抑郁严重程度。
根据照料者的报告,89%的干预组患者触发了至少1项针对痴呆症行为和心理症状的方案,平均每名患者触发4项,共有8项可能的方案。干预组患者更有可能接受胆碱酯酶抑制剂(79.8%对55.1%;P = 0.002)和抗抑郁药(45.2%对27.5%;P = 0.03)。在12个月时(平均差异,-5.6;P = 0.01)和18个月时(平均差异,-5.4;P = 0.01),通过NPI总分测量,干预组患者的痴呆症行为和心理症状明显更少。干预组照料者在12个月时通过照料者NPI报告痛苦有显著改善;在18个月时,通过患者健康问卷-9测量,照料者的抑郁有改善。在CSDD、认知、日常生活活动或住院率、养老院安置率或死亡率方面未发现组间差异。
对阿尔茨海默病进行协作护理可显著改善初级保健患者及其照料者的护理质量以及痴呆症的行为和心理症状。这些改善是在未显著增加抗精神病药物或镇静催眠药物使用的情况下实现的。
clinicaltrials.gov标识符:NCT00246896。